Covidien has announced the launch of its Nellcor SpO2 single parameter module for use with the Philips IntelliVue patient monitoring platform, according to a news release. The Nellcor SpO2 module ...
Royal Philips has designed a new FDA-cleared and CE mark approved mobile app, called IntelliVue GuardianSoftware, that gives clinicians updates on a patient’s condition and deterioration. The latest ...
Continuous monitoring provides informed, timely clinical decision making and comprehensive, gap-free patient records in the cath lab and beyond Health systems strive to deliver consistent quality ...
Philips’ IntelliVue Patient Monitors MX750/MX850, IntelliVue 4-Slot Module Rack FMX-4 and IntelliVue Active Displays AD75/AD85 receive FDA Emergency Use Authorization for use in the US during the ...
More than a year after doling out an emergency use authorization for a handful of Philips’ IntelliVue patient monitoring devices, the FDA is doubling down on the regulatory nod. Two of the patient ...
FDA 510(k) clearance of latest Philips IntelliVue patient monitor software helps drive alarm management strategies toward a more peaceful, healing environment for patients and caregivers Amsterdam, ...
St. Joseph, Mich.-based Lakeland Health entered into an agreement with Royal Philips to utilize the Philips IntelliVue Guardian Solution with automated early warning scoring at all three of its ...
Amsterdam, the Netherlands - Philips Medical Systems has announced FDA market clearance for its IntelliVue Patient Monitoring System, a device that allows doctors to be at the patient's bedside and ...
Dutch health tech giant Royal Philips has scored FDA 510(k) clearance for its IntelliVue MX750 and MX850 patient monitors. The monitors, which received an FDA emergency use authorization in 2020 and ...
A portfolio of technological solutions, created by Royal Philips Electronics, allows healthcare providers to monitor patients in general care settings, according to a company news release. The ...
Amsterdam, the Netherlands and Irvine, California, U.S. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Masimo (NASDAQ: MASI), a global medical technology company, ...
A year after they were given an emergency nod to be used during the pandemic, two of Royal Philips’ newest patient monitors now are cleared by the Food and Drug Administration. The agency recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results